About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

No Patents in a Pandemic

20 years of Advocacy in Action

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

WHA-397140

Events |

21 May 2023

MSF at the 76th World Health Assembly

MSF activities at the 76^th session of the World Health Assembly (WHA), 21-30 May 2023.

Read more

Photograph by UN Photo/Eskinder Debebe

Latest news

Press release |

26 May 2023

MSF welcomes important resolution at World Health Assembly to strengthen countries’ disease testing capacity

Events |

24 May 2023

Event: Ensuring equity in pandemics: Lessons learnt from Ebola therapeutics R&D and access constraints

Report |

24 May 2023

Ensuring Access to New Treatments for Ebola Virus Disease

Technical brief |

22 May 2023

Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?

Press release |

11 May 2023

Access to point-of-care tests for people with advanced HIV under threat as diagnostics corporations to stop production

Technical brief |

11 May 2023

Make It Count: Access to Point-of-Care CD4 Testing Under Threat

Press release |

03 May 2023

MSF calls on Gilead to finally fulfil access promise and make lifesaving drug for people with HIV available where needed

Video |

03 May 2023

Access challenges for HIV opportunistic infection drug L-AmB

Press release |

26 April 2023

MSF responds to European Commission’s proposal to revise EU’s pharma legislation

Press release |

26 April 2023

MSF demands J&J give up its patent monopoly on TB drug to put lives over profits

Press release |

20 April 2023

Gavi and donors must expand vaccine supply to catch up children up to age five

Technical brief |

07 April 2023

Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft

Publications

Report cover image

Report |

24 May 2023

Tropical & neglected diseases

Ensuring Access to New Treatments for Ebola Virus Disease

Report Cover Image

Technical brief |

22 May 2023

Research and development

Roundtable: Disclosing Clinical Trial Costs – Why and How Should It Be Done?

Report Cover Image

Technical brief |

11 May 2023

Diagnostics HIV/AIDS

Make It Count: Access to Point-of-Care CD4 Testing Under Threat

Report cover image

Technical brief |

07 April 2023

Intellectual property and trade

Pandemic Accord: MSF’s Comments on Equity Provisions in Zero Draft

Read, watch, share

Dr Zulfiya Dustmatova works as a medical doctor with MSF in Tajikistan, where our teams work with the Ministry of Health and Social Protection to diagnose and treat children with drug-resistant TB (DR-TB).

Blog |

01 March 2023

One step at a time: Improving treatment options for children with drug-resistant TB in Tajikistan

Zara Ahmat, 20, with her baby, Aba Abdulaziz, 1, just vaccinated against measles, Chad, 2019.

Photograph by Juan Haro

Press release |

13 February 2023

Vaccines

New Gavi CEO must prioritise catch-up vaccination and increase inclusive engagement

2 min

Jepngok Kiptui was just three when she was bitten by a snake while sleeping in her bed at home in Baringo County, North-Western Kenya. It took more than five hours to get her to the county’s main referral hospital, after being referred from two hospitals that lacked the capacity to treat her. Little Cheptui had to undergo three surgeries: the first to remove the dead tissues killed by the snake’s venom, and two skin grafting surgeries. Photograph by Paul Odongo

Blog |

09 February 2023

Tropical & neglected diseases

Snakebite reflecting on the neglected disease

WHO Executive Board's Special Session on Ebola

UN Photo/Christopher Black

Events

Events |

01 February 2023

MSF statements at WHO Executive Board 152nd session

1 min

Yusufa Adam, 5 years, received treatment for noma in the Sokoto hospital.

Photograph by Ghada Safaan

Press release |

26 January 2023

Tropical & neglected diseases

MSF calls for increased global investment ahead of World NTD Day

6 min

Dilaram, a former TB-PRACTECAL clinical trial patient, in Nukus, Karakalpakstan, Uzbekistan.

Blog |

17 January 2023

New, shorter treatment brings hope for TB patient Dilaram

A bottle with bedaquiline.

Photo credit: MSF/Alexandra Sadokova

Press release |

16 January 2023

India

India must reject Johnson & Johnson’s attempt to extend monopoly on lifesaving TB drug bedaquiline

4 min

Medical cooler box for the transportation of specimens (blood/sputum) from the point of specimen collection to the laboratory, used for the TB-PRACTECAL clinical trial. Clinical laboratory specimens must be transported at proper temperatures in order to preserve the viability and integrity of the specimen.

Photograph by Alexandra Sadokova

Press release |

22 December 2022

TB-PRACTECAL: Groundbreaking MSF trial finds better treatment for people with drug-resistant tuberculosis

100 years of insulin

Video |

14 April 2021

100 years of insulin

Read more

COVID-19 TRIPS Christos Christou Video

Video |

09 March 2021

MSF International President appeals to governments blocking landmark COVID-19 proposal

Read more

COVID-19: No patents or profiteering in a pandemic

Video |

20 May 2020

COVID-19: No patents or profiteering in a pandemic

Read more

No monopolies - Acccess to COVID19 treatment/Brazil

Video |

06 April 2020

No monopolies - Access to COVID-19 treatment

Read more

AC20 Lives over profit video

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Read more

A Snapshot of the Access Campaign in 2017

Video

A Snapshot of the Access Campaign

Read more

Video thumbnail

100 years of insulin

Video thumbnail

MSF International President appeals to governments blocking landmark COVID-19 proposal

Video thumbnail

COVID-19: No patents or profiteering in a pandemic

Video thumbnail

No monopolies - Access to COVID-19 treatment

Video thumbnail

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Video thumbnail

A Snapshot of the Access Campaign

Lives over profit

20 Years of Advocacy in Action - JOIN US!

Our work

Drug-resistant infections

Tropical & neglected diseases

Patents & intellectual property

Research & development

Video

Lives Over Profit: a Patient, a Doctor and a Lawyer Take Action

Read more

AC20 Lives over profit video